After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
New drugs give small-cap companies opportunity to expand markets and revenues.
The beaten-down biotech sector is making an impressive comeback. The sector seems to be rebounding after tumbling by more than 40%.
The sector seems to be rebounding after tumbling by more than 40%.
Trade-Ideas LLC identified Merrimack Pharmaceuticals (MACK) as a strong on high relative volume candidate
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.